23 In Enterobacteriaceae , a variety of -lactamases, including extended-spectrum -lactamases (ESBLs) and carbapenemases (KPC, NDM, VIM, OXA), are present and confer resistance against last-resort antibiotics like carbapenems
For example, a small pilot study might suggest benefits, but without larger, randomized controlled trials, these results are not reliable
GLP-1 Medications Show Promise for Improving HS Symptoms February 23, 2026 Authors: Allison Hanka, College of Biological Sciences, University of Minnesota, Minneapolis, MN Jordyn Nepper, BS, Department of Dermatology, University of Minnesota, Minneapolis, MN Noah Goldfarb, MD, Associate Professor, Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN Why was this research done
HSA and FSA accounts are eligible, and no insurance or membership is required
The safety profile of retatrutide, even as a standalone agent, is still being characterised through ongoing trials
Insights into the structure, function, and ligand discovery of the large neutral amino acid transporter 1, LAT1